[en] Chronic respiratory diseases (CRDs) are major non-communicable diseases (NCDs) that induce a significant burden. Asthma often occurs along the life cycle from early childhood, affecting 30 million children and adults under 45 years of age in Europe. Chronic obstructive pulmonary disease (COPD) has an estimated annual death rate of over 3 million people globally. The annual direct and indirect costs in the 28 European Union (EU) countries due to COPD or asthma are estimated at 48 billion euros and 34 billion euros respectively. Rhinitis occurs in over 100 million people in Europe, and indirect costs are enormous. Asthma is a common risk factor for COPD. CRDs impact ageing and should be prevented, recognised and managed across the life cycle to promote active and healthy ageing (AHA). There is an urgent need to act globally.
European Innovation Partnerships (EIPs) aim to enhance EU competitiveness and tackle societal challenges through research and innovation. To tackle the potential of ageing in the EU, the European Commission, within its Innovation Union policy, launched the EIP on AHA (between the Directorate General for Health and Food Safety (DG Santé) and Directorate General for Communications Networks, Content and Technology (DG CONNECT)). The B3 Action Plan promotes integrated care models for chronic diseases, including the use of remote monitoring.
The initiative AIRWAYS-ICPs (integrated care pathways for airway diseases) has been approved by the EIP on AHA as the model of chronic diseases of the B3 Action Plan. It is a Research Demonstration Project of the World Health Organization's Global Alliance against Chronic Respiratory Diseases (GARD). AIRWAYS-ICPs was initiated in 2013 by the WHO Collaborating Centre of Montpellier and the EIP on AHA Reference Site MACVIA-LR (Contre les MAladies Chroniques Pour un Vieillissement Actif en Languedoc-Roussillon, France) led by the Région Languedoc-Roussillon (France).
Bousquet J, Dahl R, Khaltaev N. Global alliance against chronic respiratory diseases. Allergy 2007; 62: 216-223.
Bousquet J, Khaltaev N. eds. Global surveillance, prevention and control of Chronic Respiratory Diseases. A comprehensive approach. Geneva, World Health Organization, 2007.
Gibson GJ, Loddenkemper R, Lundback B, et al. Respiratory health and disease in Europe: The new European Lung White Book. Eur Respir J 2013; 42: 559-563.
Zuberbier T, Lotvall J, Simoens S, et al. Economic burden of inadequate management of allergic diseases in the European Union: A GA(2) LEN review. Allergy 2014; 69: 1275-1279.
Svanes C, Sunyer J, Plana E, et al. Early life origins of chronic obstructive pulmonary disease. Thorax 2010; 65: 14-20.
Perret JL, Dharmage SC, Matheson MC, et al. The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age. Am J Respir Crit Care Med 2013; 187: 42-48.
Bousquet J, Michel J, Standberg T, et al. The European Innovation Partnership on Active and Healthy Ageing: The European Geriatric Medicine introduces the EIP on AHA Column. Eur Geriatr Med 2014; 5: 361-362.
Bousquet J, Addis A, et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J 2014; 44: 304-323.
Bousquet J, Bourquin C, Augé P, et al. MACVIA-LR Reference Site of the European Innovation Partnership on Active and Healthy Ageing. Eur Geriatr Med 2014; 5: 406-415.
Bousquet J, Schunemann HJ, Samolinski B, et al. Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol 2012; 130: 1049-1062.
Bousquet J, Burney PG, Zuberbier T, et al. GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic'. Allergy 2009; 64: 969-977.
Selroos O, Kupczyk M, Kuna P, et al. National and regional asthma programmes in Europe. Eur Respir Rev 2015. 24: 474-483.
Portuguese National Programme for Respiratory Diseases 2012-2016. Portuguese Directorate General of Health. 2012.
Haahtela T, Tuomisto LE, Pietinalho A, et al. A 10 year asthma programme in Finland: major change for the better. Thorax 2006; 61: 663-670.
Haahtela T, von Hertzen L, Makela M, et al. Finnish Allergy Programme 2008-2018-time to act and change the course. Allergy 2008; 63: 634-645.
Kinnula VL, Vasankari T, Kontula E, et al. The 10-year COPD Programme in Finland: effects on quality of diagnosis, smoking, prevalence, hospital admissions and mortality. Prim Care Respir J 2011; 20: 178-183.
Boulet LP, FitzGerald JM, Levy ML, et al. A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care. Eur Respir J 2012; 39: 1220-1229.
Reddel HK, Bateman ED, Becker A, et al. A summary of the new GINA strategy: A roadmap to asthma control. Eur Respir J 2015; 46: 622-639.
Vestbo J, Hurd SS, Agusti AG, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary. Am J Respir Crit Care Med 2013; 187: 347-365.
Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014; 43: 343-373.
Package of essential noncommunicable (PEN) disease interventions for primary health care in low-resource settings. Cancer, diabetes, heart disease and stroke, chronic respiratory disease. Geneva, World Health Organization, 2010.
Fairall L, Bateman E, Cornick R, et al. Innovating to improve primary care in less developed countries: towards a global model. BMC Innovations 2015. 1: 196-203.
Bousquet J, Mantzouranis E, Cruz AA, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol 2010; 126: 926-938.
Bousquet J, Anto JM, Demoly P, et al. Severe chronic allergic (and related) diseases: A uniform approach-A MeDALL-GA2LEN-ARIA position paper. Int Arch Allergy Immunol 2012; 158: 216-231.
Bousquet J, Jorgensen C, Dauzat M, et al. Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies. Curr Pharm Des 2014; 20: 5928-5944.
Bousquet J, Schunemann HJ, Fonseca J, et al. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation. Allergy 2015; 70: 1372-1392.
Bousquet J, Schunemann HJ, Bousquet PJ, et al. How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement. Allergy 2011; 66: 765-774.
Bousquet J, Schunemann HJ, Zuberbier T, et al. Development and implementation of guidelines in allergic rhinitis-an ARIA-GA2LEN paper. Allergy 2010; 65: 1212-1221.
Brozek JL, Baena-Cagnani CE, Bonini S, et al. Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update. Allergy 2008; 63: 38-46.
Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010; 126: 466-476.
Samolinski B, Raciborski F, Bousquet J, et al. Development of Senioral Policy in Poland. Eur Geriatr Med 2015; 7: in press.
Bousquet J, Kuh D, Bewick M, et al. Operational definition of active and healthy ageing (AHA): Report of the meeting held in Montpellier October 21,22-2012. Eur Geriatr Med 2015; 6: 196-200.
Bertens LC, Reitsma JB, van Mourik Y, et al. COPD detected with screening: impact on patient management and prognosis. Eur Respir J 2014; 44: 1571-1578.
Hernandez C, Alonso A, Garcia-Aymerich J, et al. Integrated care services: lessons learned from the deployment of the NEXES project. Int J Integr Care 2015; 15: e006.
Bousquet J, Grouse L, Zhong N. The fight against chronic respiratory diseases in the elderly: The European Innovation Partnership on Active and Healthy Aging and beyond. J Thorac Dis 2015; 7: 108-110.
Lodrup Carlsen KC, Haahtela T, Carlsen KH, et al. Integrated Allergy and Asthma Prevention and Care: Report of the MeDALL/AIRWAYS ICPs Meeting at the Ministry of Health and Care Services, Oslo, Norway. Int Arch Allergy Immunol 2015; 167: 57-64.
Bousquet J, Tanasescu CC, Camuzat T, et al. Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing. A debate at the European Union Parliament. Allergy 2013; 68: 555-561.
Samolinski B, Fronczak A, Kuna P, et al. Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union. Allergy 2012; 67: 726-731.
Samolinski B, Fronczak A, Wlodarczyk A, et al. Council of the European Union conclusions on chronic respiratory diseases in children. Lancet 2012; 379: e45-e46.
Bousquet J, Anto JM, Berkouk K, et al. Developmental determinants in non-communicable chronic diseases and ageing. Thorax 2015; 70: 595-597.
Kupczyk M, Haahtela T, Cruz AA, et al. Reduction of asthma burden is possible through National Asthma Plans. Allergy 2010; 65: 415-419.
